Emcure to acquire remaining stake in Zuventus Healthcare
The transaction is expected to close in Q2 FY 2026
The transaction is expected to close in Q2 FY 2026
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
his is the second license extension of a Nurix autoimmune disease program by Sanofi in the last 90 days
Subscribe To Our Newsletter & Stay Updated